MS: Busting the Myths
August 18, 2017
The below disease modifying treatments (DMT’s) are available for the treatment of MS in New Zealand. First line treatments for Relapsing Remitting MS (funded) Ocrevus® (Ocrelizumab) Gilenya® (Fingolimod) Aubagio® (teriflunomide) Tecfidera® (Dimethyl fumarate) Tysabri® (Natalizumab) Second line treatments for […]
